Health Condition 1: null- Androgenetic Alopecia
Conditions
Interventions
Intervention1: Dutasteride: 0.5 mg oral Dutasteride, OD (once daily), for six months
Control Intervention1: Finasteride: 1 mg oral Finasteride, OD (once daily), for six months
Sponsors
Lokmanya Tilak Municipal Medical College General Hospital
Eligibility
Inclusion criteria
Inclusion criteria: AGA with Grade 3v(vertex), grade IV or grade V of Modified Hamilton Norwood AGA with female pattern hair loss - graded as F1, F2 or F3 as per BASP classification. Patient who are willing to give consent to participate in the study.
Exclusion criteria
Exclusion criteria: Use of minoxidil within previous 6 months Use of drugs with androgenetic/anti-androgenetic properties within previous 6 months History of breast cancer/ prostate cancer/ first degree relative with prostate cancer before the age of 50 Use of drugs that cause hypertrichosis (phenytoin, acetazolamide, cyclosporine, diazoxide, psoralens, minoxidil, penicillamine, streptomycin, cortisone) and hypotrichosis(anti-coagulants, retinoids, lithium, beta blockers) in the past 6 months Uncontrolled Diabetes mellitus or hypertension Chronic smokers or tobacco chewers Hair Transplantation or hair weaving within 6 months Light or laser treatment of scalp within previous 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total, thick and thin hair countTimepoint: Basline and 24 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Blinded and non-blinded evaluation of global photographsTimepoint: 24 weeks;Inter-investigator comparison of Global photography evauationTimepoint: 24 weeks;Subjective evaluationTimepoint: 24 weeks | — |
Countries
India
Contacts
Public ContactSujit Shanshanwal
Lokmanya Tilak Municipal Medical College & General Hospital
Outcome results
None listed